Selecting and Sequencing Therapies to Improve Outcomes in Patients With Lymphoma

Video

Key opinion leaders describe when to refer a patient with lymphoma and at what point treatments should be switched, and the evolution of T-cell engaging therapies.

Recent Videos
Barriers to access and financial toxicities are challenges that must be addressed for CAR T-cell therapies in LBCL, according to Jose Sandoval Sus, MD.
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Related Content